In GBM cells, there is a notable upregulation of STEAP3 expression in comparison to that in normal brain tissues, an expression which consequently makes STEAP3 emerge as a potential prognostic marker, with elevated STEAP3 levels being associated with diminished overall survival (OS) rates [75,76]. Here, STEAP3 is linked to glioblastoma.